Evofem Biosciences
(OTC) EVFM
Evofem Biosciences Financials at a Glance
Market Cap
$1.05M
Revenue (TTM)
$20.24M
Net Income (TTM)
-$6.05M
EPS (TTM)
-$0.05
P/E Ratio
-0.16
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Price
$0.01
Volume
405,890
Open
$0.01
Price
$0.01
Volume
405,890
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.02
Estimated Earnings Date
Aug 19, 2026
Dividend
$0.00
Beta (Volatility)
0.48 (Low)
Price
$0.01
Volume
405,890
Open
$0.01
Previous Close
$0.01
Daily Range
$0.01 - $0.01
52-Week Range
$0.00 - $0.02
Estimated Earnings Date
Aug 19, 2026
EVFM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evofem Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
29
CEO
Saundra L. Pelletier
Website
www.evofem.comHeadquarters
San Diego, CA 92130, US
EVFM Financials
Key Financial Metrics (TTM)
Gross Margin
74%
Operating Margin
-17%
Net Income Margin
-30%
Return on Equity
0%
Return on Capital
5%
Return on Assets
-81%
Earnings Yield
-6.25%
Dividend Yield
0.00%
Payout Ratio
-2.21%
Stock Overview
Market Cap
$1.05M
Shares Outstanding
132.53M
Volume
405.89K
Avg. Volume
215.14K
Financials (TTM)
Gross Profit
$15.07M
Operating Income
$1.44M
EBITDA
$2.07M
Operating Cash Flow
-$1.99M
Capital Expenditure
-$5.00K
Free Cash Flow
-$2.00M
Cash & ST Invst.
$578.00K
Total Debt
$65.87M
Evofem Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$899.00K
+6.4%
Gross Profit
$414.00K
-13.8%
Gross Margin
46.05%
N/A
Market Cap
$1.05M
N/A
Market Cap/Employee
$32.72K
N/A
Employees
32
N/A
Net Income
-$5.49M
-673.7%
EBITDA
-$4.46M
-901.8%
Quarterly Fundamentals
Total Cash
$2.38M
+976.5%
Total Debt
$66.92M
+46.3%
Accounts Receivable
$560.00K
-51.3%
Inventory
$1.89M
-16.5%
Long Term Debt
$27.00K
+440.0%
Short Term Debt
$66.89M
+46.3%
Return on Assets
-81.30%
N/A
Return on Invested Capital
4.85%
N/A
Free Cash Flow
$2.30M
+310.5%
Operating Cash Flow
$2.30M
+310.9%